I am a researcher and PhD Candidate in Health Services Research and Health Policy with a concentration in Health Economics at the Emory University Rollins School of Public Health. My anticipated PhD completion is May 2027.

My primary research interests are around medication access and insurance coverage and payment policy in the US. My current research focuses on cardioprotective glucose-lowering drugs for the treatment of diabetes, namely GLP-1 receptor agonists and SGLT2 inhibitors.

I previously worked with the Duke University Margolis Center for Health Policy on issues impacting access to high-cost biologics and cell and gene therapies, and as a life sciences economic and policy consultant in Washington, DC. I received my bachelor’s degree in Economics and Philosophy from Swarthmore College in Pennsylvania.